3

PRIMARY DOCUMENT

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: February 1, 2010
Period of Report: January 20, 2010
Accession Number: 0001250853-10-000009

View Document ↗ View on SEC.gov ↗